« Previous | Next » | All Messages |  PMED Message Board Home | recommend post |  Ignore Poster

PMED News Paradigm Medical Industries to Introduce Several New Instruments at AAO Convention

SALT LAKE CITY--(BUSINESS WIRE)--Paradigm Medical Industries, Inc. (OTCBB: PMED/PMEDW), a leading innovative producer of ultrasound devices for the ophthalmic and medical industries, disclosed today it has finalized an agreement with Tinsley, a division of Hartest Precision Instruments, Ltd. (Croydon, UK), whereby the latter will construct a new-generation compact Visual Field Screener (VFS) Perimeter on behalf and for Paradigm Medical. The new LD700 Perimeter measures visual field loss caused by glaucoma, head trauma, or other neurological disorders that can impact the visual pathways. It will be marketed by Paradigm Medical on a global scale.

Paradigm Medical’s Dicon™ Perimeters already are a standard of care in the protection and monitoring of glaucoma worldwide.

“The LD700 will be our third-generation perimeter,” noted Paradigm Medical’s Chief Executive Officer, Raymond Cannefax. “It already has received U.S. Food & Drug Administration and European CE Mark regulatory approval. We will introduce this new, state-of-the-art device at the American Academy of Ophthalmology (AAO) Convention next month in Las Vegas.”

Paradigm Medical reported it will also be launching domestically several other sophisticated ultrasound devices and instruments at AAO, some of which have been developed via its agreement with MEDA Corp., one of China’s leading developers and producers of ultrasound devices. That agreement was completed in June 2006. Paradigm Medical is already selling some of these devices in international markets, where customer response has been very positive.

The new instruments include an Ultrasound A-Scan (which is used to measure axial length of the eye), a Pachymeter (which is used for measuring corneal thickness), an A-Scan/Pachymeter (which is a combination of the two stand-alone devices), and two A/B Scans (one is an ultrasound imaging device for detecting abnormalities within the eye; the second is designed to provide portability for ophthalmology veterinary applications).

“We are unaware of any other company that has introduced so many ophthalmic devices/instruments at any one time within the industry,” Mr. Cannefax said. “It represents further validation of our strategy to upgrade the Company’s product offerings and broaden the global market opportunity for sophisticated, high-tech, high-value-added instrumentation for the detection, treatment and management of ophthalmic disease.

“We believe our expanded portfolio should provide our customers, suppliers, competitors and employees with evidence that Paradigm Medical is making significant progress in repositioning itself as a strong force in the global ophthalmic market. We have also shown that we can work with other industry leaders in creating next-generation instrumentation to combat eye disease,” Mr. Cannefax added.

Paradigm Medical Industries, Inc. (Salt Lake City, UT), currently develops, manufactures and markets high-tech, proprietary diagnostic equipment and consumable products for the medical industry. The Company is a leading developer of Ultrasound devices, and has been dubbed “The UBM Company” (Ultrasound BioMicroscope). Contact us at 801-977-8970 or visit us at www.paradigm-medical.com.

This press release contains statements that, if not verifiable historic fact, may be viewed as forward-looking statements that could predict future events and outcomes with respect to Paradigm and its business. The predictions embodied in these statements will involve risk and uncertainties and, accordingly, actual results may differ significantly from the results discussed or implied in such forward-looking statements.